Associated Retinal Consultants P.C. (ARC) - Royal Oak — Royal Oak, Michigan

Associated Retinal Consultants P.C. (ARC) - Royal Oak is a clinical research site located in Royal Oak, Michigan, United States 48073.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Associated Retinal Consultants P.C. (ARC) - Royal Oak has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration.

Sponsors: Ocular Therapeutix, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Royal Oak

Browse all research sites in Michigan · View every site in Royal Oak

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Associated Retinal Consultants P.C. (ARC) - Royal Oak?

Associated Retinal Consultants P.C. (ARC) - Royal Oak has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Associated Retinal Consultants P.C. (ARC) - Royal Oak conducted?

Associated Retinal Consultants P.C. (ARC) - Royal Oak has 1 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-Related Macular Degeneration.

Is Associated Retinal Consultants P.C. (ARC) - Royal Oak accredited by Crixeo Clinical Trials?

Associated Retinal Consultants P.C. (ARC) - Royal Oak has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Associated Retinal Consultants P.C. (ARC) - Royal Oak?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.